Arcellx (ACLX) is positioned to disrupt multiple myeloma cell therapy with anito-cel, leveraging superior efficacy, safety, ...

Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, ...

A senior oncologist explains why in India, where the cancer burden continues to rise, these advancements carry heightened ...

Incyte today announced that the European Commission (EC) has approved Minjuvi® (tafasitamab) in combination with lenalidomide and rituximab for the treatment of adult patients with relapsed or ...

Ethyl acetate was identified as the most effective solvent for cannabinoid extraction from cannabis oil and marijuana samples. The validated UHPLC-LTQ-MS method offers high sensitivity, selectivity, ...

The organisers claim the Enhanced Games are a science-backed effort to help humans reach their full physical potential, while ...

A growing number of new studies have found that, at least for some cells, death isn’t the end, but the beginning of something ...

New research has mapped the cell types that specialize to form reproductive organs in both sexes, identifying key genes and ...

EPSO-G has announced the selection of board members for its company, Energy Cells. Candidates are invited to submit their ...

A vesicle, only a few nanometers in size and filled with neurotransmitters, approaches a cell membrane, fuses with it, and ...

Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and ...

Washington Research Foundation (WRF) has awarded three-year postdoctoral fellowships to a new cohort of 12 early-career researchers who will pursue innovative, high-impact projects in the natural ...